<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680444/" ref="ordinalpos=4759&amp;ncbi_uid=5002526&amp;link_uid=PMC3680444" image-link="/pmc/articles/PMC3680444/figure/pone-0063676-g008/" class="imagepopup">Figure 8. ATDC up-regulates Cyclin D1 and c-Myc via activation of NF-κB <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span>..  From: Ataxia-Telangiectasia Group D Complementing Gene (ATDC) Promotes Lung Cancer Cell Proliferation by Activating NF-?B <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">A. ATDC overexpression up-regulated NF-κB reporter luciferase activity in HBE cells and ATDC depletion inhibited NF-κB reporter luciferase activity in both A549 and H1299 cells. B. ATDC transfection increased p-IκB expression in HBE cells and ATDC depletion decreased the level of p-IκB in A549 and H1299 cells. C. NF-κB inhibitor Bay 11-7082 completely blocked NF-κB reporter luciferase activity and reversed the effect of ATDC on cyclin D1, c-Myc and p-Rb up-regulation.</div></div>